Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-24Clinical Trial Update: Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM) [NA]
This entry notes that a clinical trial investigating the effects of monosodium glutamate on irritable bowel syndrome and fibromyalgia has co…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Improving Quality of Life of Fibromyalgia Patients [NA]
A completed clinical trial evaluating strategies to improve quality of life for patients with fibromyalgia.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Qigong vs. Aerobic Exercise in the Treatment of Childhood Chronic Musculoskeletal Pain [Phase 2]
Phase 2 trial comparing qigong to aerobic exercise for childhood chronic musculoskeletal pain has completed; the study is sponsored by The H…
-
FDA approval · 2013-12-17FDA Approved: DULOXETINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for a generic duloxetine product. The approval makes low-cost generic duloxetine av…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic duloxetine hydrochloride product from Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome. [NA]
A completed clinical trial evaluating physiotherapy for temporomandibular joint dysfunction in patients with fibromyalgia.
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (MARKSANS PHARMA LIMITED)
FDA approves duloxetine hydrochloride generic by Marksans Pharma Limited under an Original ANDA (ANDA 090723).
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for a generic duloxetine product (DULOXETINE). This approval allows the mar…
-
FDA approval · 2013-12-11FDA Approved: DULOXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic duloxetine under an Original Application, authorizing a generic version of the reference duloxet…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises [Phase 4]
A Phase 4 clinical trial evaluated the effects of strengthening exercises on heart rate variability in fibromyalgia. The study has completed…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Support, Health, and Fibromyalgia [Phase 2]
Phase 2 clinical trial on fibromyalgia focusing on support and quality of life has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Sleep and Pain Interventions in Fibromyalgia [NA]
A clinical trial investigating sleep and pain interventions in Fibromyalgia has completed. The study involved participants with Fibromyalgia…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Behavioral Treatment of Fibromyalgia [Phase 2]
This update reports the completion of a Phase 2 trial evaluating a behavioral treatment for fibromyalgia.
-
FDA approval · 2013-11-25FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Coping Skills Training for Adolescents With Fibromyalgia [Phase 3]
A Phase 3 clinical trial evaluating coping skills training for adolescents with fibromyalgia has completed with posted results.
-
FDA approval · 2013-10-30FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Tailored Treatments of Fibromyalgia [Phase 2, Phase 3]
The University of Washington conducted Phase 2 and Phase 3 trials of tailored treatments for fibromyalgia. The study status is completed.
-
CLINICAL_TRIALS research · 2013-10-10Clinical Trial Update: Computerized Cognitive Testing in Patients Suffering From Fibromyalgia
An update on a clinical trial studying computerized cognitive testing in fibromyalgia patients. The current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia [Phase 2]
A Phase 2 long-term safety and efficacy study of milnacipran in pediatric patients with fibromyalgia was terminated. Results have been poste…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: D-Ribose for Fatigue in Subjects With Fibromyalgia [Phase 2]
Phase 2 clinical trial evaluating D-Ribose for fatigue in subjects with fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Cognitive Dysfunction in Fibromyalgia Patients
A clinical trial evaluating cognitive dysfunction in fibromyalgia patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Fibromyalgia Treatment Trial With Gabapentin and Osteopathic Manipulative Medicine [Phase 3]
Phase 3 trial evaluating gabapentin in combination with osteopathic manipulative medicine for fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome [Phase 3]
Phase 3 trial results update evaluating growth hormone for neuroendocrine dysfunction in patients with severe fibromyalgia syndrome.
-
CLINICAL_TRIALS research · 2013-08-01Clinical Trial Update: Combining N-of-1 Trials to Assess Fibromyalgia Treatments [Phase 4]
This update describes using a combined N-of-1 trial approach to evaluate fibromyalgia treatments in a Phase 4 study sponsored by Tufts Medic…
-
CLINICAL_TRIALS research · 2013-07-22Clinical Trial Update: Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS [Phase 2]
A Phase 2 clinical trial investigating functional neuroimaging changes in fibromyalgia patients undergoing transcranial direct current stimu…